The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development…
Continue Reading →
Arcturus Therapeutics is a growing company with a versatile portfolio and cutting-edge mRNA technology that can be adapted to multiple disease areas. New to clinical…
Continue Reading →
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
Continue Reading →
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…
Continue Reading →
The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of…
Continue Reading →
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for…
Continue Reading →
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President,…
Continue Reading →
The Chase Group, known for relationship building with proven success in life sciences executive search, was retained by Akcea Therapeutics, to identify and secure a…
Continue Reading →
Following an extensive search of industry and academic professionals by The Chase Group, the Allen Institute for Immunology welcomes a new Director, Informatics & Computational…
Continue Reading →
After a comprehensive executive search that was filled in less than two months, The Chase Group is pleased to announce the placement of Carla Poulson…
Continue Reading →